Cancer Tumor Profiling Global Market Size, Share, Growth, Trends And Industry Forecast 2023-2032

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company's Cancer Tumor Profiling Global Market Report 2023 identifies the increasing incidences of cancer as the major driver for the cancer tumor profiling market's growth in the forecast period. Cancer is a disease in which some cells in the body get uncontrollably large and spread to other parts of the body. As the number of cancer cases rises, so does the demand for cancer tumor profiling, which enables doctors to determine the severity of the disease.

The global cancer tumor profiling market size grew from $9.62 billion in 2022 to $11.12 billion in 2023 at a compound annual growth rate (CAGR) of 15.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the cancer tumor profiling is expected to grow to $18.18 billion in 2027 at a CAGR of 13.1%.

Download Free Sample Of Cancer Tumor Profiling Market Report -
https://www.thebusinessresearchcompany.com/sample_request?id=6053&type=smp

Major competitors in the cancer tumor profiling market are F. Hoffmann-La Roche Ltd., Caris Life Sciences, Thermo Fisher Scientific Inc., Illumina Inc., QIAGEN.

A key trend in the cancer tumor profiling market includes the increasing research and development activities. Major companies operating in cancer and tumor profiling sector are focused on research and development activities to meet consumer demand and reinforce their position. For instance, in February 2020, QIAGEN N.V, a German company that develops sample and assay technology for applied testing, pharmaceutical development, molecular diagnostics, and academic research announced the Conformitè Europëenne (CE)-marking and commercialization of therascreen PIK3CA RGQ PCR Kit in Europe as a tool to help identify breast cancer patients with PIK3CA mutations. The therascreen PIK3CA test is a diagnostic assay for the detection of an activating mutation in the phosphatidyl 3-kinase catalytic subunit alpha (PIK3CA) gene, and first to allow testing of both DNA from plasma specimens or FFPE tissue.

Read More On The Global Cancer Tumor Profiling Market Report Here:
https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

The cancer tumor profiling market is segmented -
•By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Ovarian Cancer, Stomach Cancer, Pancreatic Cancer, Thyroid Cancer, Other Cancer Types
•By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Microarray, Other Technologies
•By Process Type: Genomics, Proteomics, Epigenetics, Metabolomics, Other Types
•By Application: Personalized Medicine, Diagnostics, Biomarker Discovery, Prognostics, Research Applications
•By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the cancer tumor profiling market.

The Business Research Company's "Global Cancer Tumor Profiling Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.

Explore Buying Options For The Cancer Tumor Profiling Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6053

The Table Of Content For The Cancer Tumor Profiling Market Include:
1. Executive Summary
2. Cancer Tumor Profiling Market Characteristics
3. Cancer Tumor Profiling Market Trends And Strategies
4. Cancer Tumor Profiling Market - Macro Economic Scenario
5. Cancer Tumor Profiling Market Size And Growth
……
26. Africa Cancer Tumor Profiling Market
27. Cancer Tumor Profiling Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Cancer Tumor Profiling Market
29. Cancer Tumor Profiling Market Future Outlook and Potential Analysis
30. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.